Form 4: Outset Medical Director Sells Shares Under 10b5-1 Plan

Outset Medical director Karen Drexler reported the sale of 1,548 shares of common stock at $4.37 per share under a pre-arranged 10b5-1 plan.

Summary

• Karen Drexler, a Director at Outset Medical, Inc. (OM), disposed of 1,548 shares of common stock.
• The transaction occurred on December 1, 2025, at a price of $4.37 per share.
• The sale was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following this transaction, Drexler directly holds 10,650 shares of common stock.
• An additional 2,083 shares are indirectly beneficially owned through the Drexler Family Trust.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine disclosure of an insider stock transaction, likely pre-scheduled under a 10b5-1 plan, and does not inherently indicate positive or negative company performance or outlook.

Stakeholder Impact

• Minimal impact on shareholders due to the relatively small number of shares sold by a director, especially given it was executed under a pre-arranged 10b5-1 plan.

Key Dates

Keywords

Outset Medical, OM, Karen Drexler, Insider Transaction, Form 4, Stock Sale, Director, Equity Disposal, 10b5-1 Plan